These 3 Stocks Trounced the S&P 500 in the First Half of 2026 -- and Wall Street Thinks 1 of Them Could Soar Even More
These stocks have jumped in the double- and triple-digits.
Overview
The S&P 500 finished the first half of the year with a win, but it wasn't without a struggle. Though the index had its ups, it also had its downs, as worries about turmoil in Iran, rising oil prices, an uncertain economy, and tech spending on artificial intelligence (AI) weighed on sentiment.
This also pushed down many of the recent stock market winners, such as AI stocks, and buoyed other potential growth names as investors shifted into new opportunities. And this brings us to the subject of the three stocks that trounced the S&P 500 in the first half of 2026. They are three biotech companies with key catalysts on the horizon, and investors recognized their potential, driving them to double- and triple-digit gains.
Details
Now, Wall Street thinks one of them could soar even more. Let's jump in for a close look.
Source
Originally published at www.fool.com.